Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

RNAi-combined nano-chemotherapeutics to tackle resistant tumors.

Tekade RK, Tekade M, Kesharwani P, D'Emanuele A.

Drug Discov Today. 2016 Nov;21(11):1761-1774. doi: 10.1016/j.drudis.2016.06.029. Review.

PMID:
27380716
2.

Variants in TNIP1, a regulator of the NF-kB pathway, found in two patients with neural tube defects.

Francesca LC, Claudia R, Molinario C, Annamaria M, Chiara F, Natalia C, Emanuele A, Valentina P, Giovanni N, Costantino R, Eugenio S, Fiorella G.

Childs Nerv Syst. 2016 Jun;32(6):1061-7. doi: 10.1007/s00381-016-3087-1. Erratum in: Childs Nerv Syst. 2016 Jul;32(7):1343.

PMID:
27125519
3.

PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.

Nasr M, Najlah M, D'Emanuele A, Elhissi A.

Int J Pharm. 2014 Jan 30;461(1-2):242-50. doi: 10.1016/j.ijpharm.2013.11.023.

PMID:
24275446
4.

Extraction and RP-HPLC determination of taxol in rat plasma, cell culture and quality control samples.

Tekade RK, D'Emanuele A, Elhissi A, Agrawal A, Jain A, Arafat BT, Jain NK.

J Biomed Res. 2013 Sep;27(5):394-405. doi: 10.7555/JBR.27.20120123.

5.

Solubility enhancement of paclitaxel using a linear-dendritic block copolymer.

Zhou Z, D'Emanuele A, Attwood D.

Int J Pharm. 2013 Aug 16;452(1-2):173-9. doi: 10.1016/j.ijpharm.2013.04.075.

PMID:
23651641
6.

Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier.

Teow HM, Zhou Z, Najlah M, Yusof SR, Abbott NJ, D'Emanuele A.

Int J Pharm. 2013 Jan 30;441(1-2):701-11. doi: 10.1016/j.ijpharm.2012.10.024.

PMID:
23089576
7.

Thermal aggregation of bovine serum albumin in trehalose and sucrose aqueous solutions.

Panzica M, Emanuele A, Cordone L.

J Phys Chem B. 2012 Oct 4;116(39):11829-36. doi: 10.1021/jp3054197.

PMID:
22845790
8.

Nanoparticles for Targeted Delivery of Active Agents against Tumor Cells.

Dinarvand R, Cesar de Morais P, D'Emanuele A.

J Drug Deliv. 2012;2012:528123. doi: 10.1155/2012/528123. No abstract available.

9.

Heparin-induced thrombocytopenia: the role of platelets genetic polymorphisms.

Pamela S, Anna Maria L, Elena D, Giovanni M, Emanuele A, Silvia V, Carmen B, Andreas G, Fabrizio F.

Platelets. 2013;24(5):362-8. doi: 10.3109/09537104.2012.701026.

PMID:
22793995
10.

Y:BaZrO3 perovskite compounds II: designing protonic conduction by using MD models.

Cammarata A, Emanuele A, Duca D.

Chem Asian J. 2012 Aug;7(8):1838-44. doi: 10.1002/asia.201100975.

PMID:
22570217
11.

Y:BaZrO3 perovskite compounds I: DFT study on the unprotonated and protonated local structures.

Cammarata A, Ordejón P, Emanuele A, Duca D.

Chem Asian J. 2012 Aug;7(8):1827-37. doi: 10.1002/asia.201100974.

PMID:
22570197
12.

Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients.

Shimoyama T, Itoh K, Kobayashi M, Miyazaki S, D'Emanuele A, Attwood D.

Drug Dev Ind Pharm. 2012 Aug;38(8):952-60. doi: 10.3109/03639045.2011.634809.

PMID:
22283456
13.

Carbon nanotubes in cancer therapy and drug delivery.

Elhissi AM, Ahmed W, Hassan IU, Dhanak VR, D'Emanuele A.

J Drug Deliv. 2012;2012:837327. doi: 10.1155/2012/837327.

14.

In situ gelling formulation based on methylcellulose/pectin system for oral-sustained drug delivery to dysphagic patients.

Itoh K, Hatakeyama T, Shimoyama T, Miyazaki S, D'Emanuele A, Attwood D.

Drug Dev Ind Pharm. 2011 Jul;37(7):790-7. doi: 10.3109/03639045.2010.541465.

PMID:
21405940
15.

Cation environment of BaCeO3-based protonic conductors II: new computational models.

Cammarata A, Emanuele A, Martorana A, Duca D.

J Phys Chem A. 2011 Mar 10;115(9):1676-85. doi: 10.1021/jp1069797.

PMID:
21314101
16.

Retrospective investigation of an influenza A/H1N1pdm outbreak in an Italian military ship cruising in the Mediterranean Sea, May-September 2009.

Tarabbo M, Lapa D, Castilletti C, Tommaselli P, Guarducci R, Lucà G, Emanuele A, Zaccaria O, La Gioia VF, Girardi E, Capobianchi MR, Ippolito G.

PLoS One. 2011 Jan 20;6(1):e15933. doi: 10.1371/journal.pone.0015933.

17.

High-throughput screening of the virulence regulator VirF: a novel antibacterial target for shigellosis.

Hurt JK, McQuade TJ, Emanuele A, Larsen MJ, Garcia GA.

J Biomol Screen. 2010 Apr;15(4):379-87. doi: 10.1177/1087057110362101.

18.

Effect of D-sorbitol on the thermal gelation of methylcellulose formulations for drug delivery.

Itoh K, Hatakeyama T, Kimura T, Shimoyama T, Miyazaki S, D'Emanuele A, Attwood D.

Chem Pharm Bull (Tokyo). 2010 Feb;58(2):247-9.

19.

Intrathecal chemotherapy and meningeal relapses in myelomonocytic AML. A single institution experience.

Romani C, Di Tucci AA, Dessalvi P, Pettinau M, Emanuele A.

Am J Hematol. 2010 Mar;85(3):219. doi: 10.1002/ajh.21606. No abstract available.

20.

In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.

Itoh K, Tsuruya R, Shimoyama T, Watanabe H, Miyazaki S, D'Emanuele A, Attwood D.

Drug Dev Ind Pharm. 2010 Apr;36(4):449-55. doi: 10.3109/03639040903244480.

PMID:
19788404
Items per page

Supplemental Content

Loading ...
Support Center